Prevalence of medical ghost-writing still a concern, warns Senator Grassley
This article was originally published in Scrip
Efforts by medical journals in recent years to strengthen their authorship and publication requirements appear to have had limited effect on ghost-writing and disclosure of industry financing of medical articles, says a new report released by US Senator Chuck Grassley (Republican – Iowa).
You may also be interested in...
The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.
An EU pilot project will assess whether there is sufficient demand from companies to obtain simultaneous scientific advice from EU national competent authorities.
An ambitious action plan drawn by an EU task force, if implemented on a priority basis by the European Commission, could increase the EU’s capacity to advise on, assess and analyze big data.